439 related articles for article (PubMed ID: 31389890)
21. Pathological fractures in predicting clinical outcomes for patients with osteosarcoma.
Chung LH; Wu PK; Chen CF; Weng HK; Chen TH; Chen WM
BMC Musculoskelet Disord; 2016 Dec; 17(1):503. PubMed ID: 28031047
[TBL] [Abstract][Full Text] [Related]
22. Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma.
Delsin LEA; Roberto GM; Fedatto PF; Engel EE; Scrideli CA; Tone LG; Brassesco MS
Pathol Oncol Res; 2019 Jan; 25(1):11-20. PubMed ID: 28944406
[TBL] [Abstract][Full Text] [Related]
23. Pathologic fracture in osteosarcoma : prognostic importance and treatment implications.
Scully SP; Ghert MA; Zurakowski D; Thompson RC; Gebhardt MC
J Bone Joint Surg Am; 2002 Jan; 84(1):49-57. PubMed ID: 11792779
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
Xu SH; Yang YL; Han SM; Wu ZH
World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
26. Role of miRNA-542-5p in the tumorigenesis of osteosarcoma.
Zhu T; Fan D; Ye K; Liu B; Cui Z; Liu Z; Tian Y
FEBS Open Bio; 2020 Apr; 10(4):627-636. PubMed ID: 32105410
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
[TBL] [Abstract][Full Text] [Related]
28. Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma.
Cai H; Lin L; Cai H; Tang M; Wang Z
Int J Mol Sci; 2014 Jan; 15(1):560-73. PubMed ID: 24398981
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
Wang G; Shen N; Cheng L; Lin J; Li K
Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
[TBL] [Abstract][Full Text] [Related]
31. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
32. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
33. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of pathologic fracture in patients with high grade localized osteosarcoma: a systemic review and meta-analysis of cohort studies.
Sun L; Li Y; Zhang J; Li H; Li B; Ye Z
J Orthop Res; 2015 Jan; 33(1):131-9. PubMed ID: 25231396
[TBL] [Abstract][Full Text] [Related]
35. Telangiectatic osteosarcoma.
Colomina J; Peiro A; Trullols L; Garcia I
J Orthop Surg (Hong Kong); 2013 Apr; 21(1):96-9. PubMed ID: 23629998
[TBL] [Abstract][Full Text] [Related]
36. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.
Yi X; Wang Y; Xu S
J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443
[TBL] [Abstract][Full Text] [Related]
37. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of hsa_circ_0136666 predicts poor prognosis and initiates osteosarcoma tumorigenesis through miR-593-3p/ZEB2 pathway.
Zhang C; Zhou H; Yuan K; Xie R; Chen C
Aging (Albany NY); 2020 May; 12(11):10488-10496. PubMed ID: 32424109
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2.
Wang L; Hu K; Chao Y; Wang X
J Cell Biochem; 2020 Feb; 121(2):2038-2046. PubMed ID: 31633240
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.
Shi ZW; Wang JL; Zhao N; Guan Y; He W
Cancer Biomark; 2016 Jun; 17(2):249-57. PubMed ID: 27540978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
